Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison

INTRODUCTION: This study aims to make an indirect comparison between enzalutamide and abiraterone acetate for mCRPC post-docetaxel. METHODS: A search for published phase 3 trials was performed with PubMed. Indirect comparisons of enzalutamide (AFFIRM) to abiraterone acetate (COU-AA-301) on outcomes...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Tan, Pui S, Haaland, Benjamin, Montero, Alberto J, Kyriakopoulos, Christos E, Lopes, Gilberto
Formato: Artigo
Idioma:Inglês
Publicado: Libertas Academica 2014
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3964205/
https://ncbi.nlm.nih.gov/pubmed/24678245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S13671
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares